- Health Topics
- The Science
- Grants and Training
- News and Events
- About NHLBI
All News
|
Statement
In large clinical trials conducted worldwide, full dose anti-coagulation (blood thinner) treatments given to moderately ill patients hospitalized for COVID-19 reduced the requirement of vital organ support—such as the need for mechanical ventilation. A trend in possible reduction of mortality was also observed and is being further studied. With...
Showing 10 out of 1390 results
|
NHLBI in the Press
A study profiles the metabolic preferences of human hearts, which supports future research to prevent and treat heart failure.
Credit: Daniel Reichart/Harvard Medical School
|
NHLBI in the Press
Scientists catalogued half a million heart cells to provide a reference for the underpinnings of cardiovascular health and disease.
|
NHLBI in the Press
Researchers are reporting that patients who had the most severe COVID-19 may be the best donors of convalescent plasma that is increasingly used to treat the disease.
|
NHLBI in the Press
“Heat-not-burn” tobacco products, newcomers the U.S. market that produce nicotine-containing vapor by heating tobacco at low temperatures, may be harmful to the heart.
|
NHLBI in the Press
The pre-hospital administration of tranexamic acid, a medication that promotes blood clotting, to patients with traumatic brain injuries did no better than placebo in lowering the risk of death.
|
NHLBI in the Press
As almost any new parent can attest, the issue of infant sleep can be a nightmare. A new study of infant sleep reveals that sleep differences by race and socioeconomic status emerge early.
|
NHLBI in the Press
More than half of older patients hospitalized for heart failure are discharged from the hospital with 10 or more medical prescriptions, according to a recently published study.
|
NHLBI in the Press
A novel study shows a machine-learning model can identify gut bacteria associated with cardiovascular health and disease.
|
NHLBI in the Press
Women ages 25-44 had a higher number of first-time strokes compared to men the same age, according to new research in Stroke. These trends reversed for men ages 45-74 and neutralized for men and women ages 75 and older.
Credit: Jessie Huang et al, Cell Stem Cell.
|
NHLBI in the Press
A team of NHLBI-funded researchers has discovered a biological pathway that triggers deadly levels of lung inflammation when activated by SARS-CoV-2, the coronavirus that causes COVID-19.